REFERENCES
- Feller, A. E.: In Harrison. T. R. (ED.): Principles of Internal Medicine. Ed. 2. Philadelphia, The Blakiston Company, 1954.
- Kneeland, Y., Jr.: In Loeb, R. (ED.): Cecil's Textbook of Medicine. Ed. 9. Philadelphia, W. B. Saunders Company, 1955.
- Dingle, J. H.: The prevention of respiratory infections within families. Ann. Int. Med. 43:518–525 (September) 1955.
- Frost, W. H. and Gover, M.: Incidence and time distribution of common colds in several groups kept under continuous observation. Pub. Health Rep. 47:1815–1841, 1932.
- Linde, J. I., Gelperin, A. and Granoff, M. A.: Causes of absenteeism in New Haven schools: Follow-up after 21 years. Pub. Health Rep. 65:1737–1744, 1950.
- Collins, S. D.: Sickness surveys. In Emerson, H. (ED.): Administrative Medicine. New York, Thomas Nelson & Sons, 1951.
- Rowe, W. P., Huebner, R. J., Gilmore, L. K., Parrott, R. H. and Ward, T. G.: Isolation of cytopathogenic agent from human adenoids undergoing spontaneous degeneration in tissue culture. Proc. Soc. Exper. Biol. & Med. 84:570–573, 1953.
- Hilleman, M. R. and Werner, J. H.: Recovery of new agent from patients with acute respiratory disease. Proc. Soc. Exper. Biol. & Med. 85:183–188, 1954.
- Evans, A. S. and Morse, H. L.: Unpublished data on experiments conducted at the University of Wisconsin in the spring of 1954.
- Jawetz, E., Kimura, S., Nicholas, A. N., Thygeson, P. and Hanna, L.: New type of APC virus from epidemic keratoconjunctivitis. Science 122:1090–1091 (December 16) 1955.
- Bell, J. R. and others: Studies of adenoviruses (APC) in volunteers. AM. J. Hyg. 46:1130–1146 (September) 1956.
- Kjellen, L.: Studies on an unidentified group of cytopathogenic agente. Arch. ges. virusforsch. 6:45–59, 1955.
- Huebner, R. J., Rowe, W. P., Ward, T. G., Parrott, R. H. and Bell, J. A.: Adenoidal-pharyngeal-conjunctival agents. A newly recognized group of common viruses of the respiratory system. New England J. Med. 251:1077, 1954.
- Neva, F. A. and Enders. J. F.: Isolation of a cytopathogenic agent from an infant with a disease in certain respects resembling roseola infantum. J. Immunol. 72:315, 1954.
- Huebnbr, R. J., Beeman, E. A., Cole, R. M., Beigelman, P. M. and Bell, J. A.: Importance of Coxsackie viruses in human disease. particularly herpangina and epidemic pleurodynia. New England J. Med. 247:249–256; 285–289, 1952.
- Evans, A. S.: Acute respiratory disease in University of Wisconsin studente. New England J. Med. (In press.)
- Jordan, W. S., Jr.: The frequency of infection with APC-RI viruses in a family study population. Presented at the conference of the Section of Biology of the New York Academy of Science, May 24–25. 1956.
- Price, W. H.: The epidemic climate. Pub. Health Rep. 71:125–138, 1956.
- Breese, B. B. and Disney, F. A.: The accuracy of diagnosis of beta streptococcal infections on clinical grounds. J. Pediat. 44:670–673 (June) 1954.
- Bell, J. A., Hantover, M. J., Huebner. R. J. and Loosli, C. G.: Efficacy of trivalent adenovirus (APC) vaccine in naval recruits. J.A.M.A. 161:1521–1525 (August 18) 1956.
- Hilleman, M. R., Stallones, R. A., Gauld, R. L., Worfield, M. S. and Anderson, S. A.: Vaccination against acute illness of adenovirue (RI-APC-ARD) etiology. Presented at the meeting of the American Public Health Association, Atlantic City, November 12, 1956.
- Kuh, C. and Collen, M. R.: Mass penicillin prophylaxis. J.A.M.A. 140:1325–1328 (August 27) 1949.
- Seal, J. R.: Mass prophylaxis of epidemic streptococcal infections. In: Antibiotics Annual, 1955–1956. New York, Medical Encyclopedia, Inc., 1956, pp. 202–216.
- Gehrand, H. C.: Experiences in prevention of upper respiratory infections in general pediatric practice. Ibid., pp. 364–373.
- Committee on Prevention of Rheumatic Fever and Bacterial Endocarditis, American Heart Association: Prevention of rheumatic fever and bacterial endocarditis through control of streptococcal infections. Circulation 11:317–320 (February) 1955.
- Cronk, G. A., Naumann, D. E., Mcdermott, K., Menter, P. and Swift, M. B.: A controlied study of the effect of oral penicillin in the treatment of nonspecific upper respiratory infections. Am. J. Med. 16:804–809 (June) 1954.